Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02739620 · ClinicalTrials.gov registry record · NA

Alternative Exercise Program to Improve Skeletal Muscle Function and Fatigue in Cancer Survivors

A NA study, sponsored by University of Vermont.

Completed
Registry status
NA
Development phase
22
Enrollment target

NCT02739620 is a NA study that has completed, run by University of Vermont. The registered enrollment target is 22 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02739620, a NA study, has completed, sponsored by University of Vermont.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target

Study Summary

Exercise training has beneficial effects in cancer survivors to minimize some of the side effects of cancer and its treatment and improve long-term prognosis, but there are numerous hurdles for individuals diagnosed with, and being treated for, cancer to participate in exercise programs. The goal of this research study is to begin to evaluate whether exercise training via neuromuscular electrical stimulation (NMES) has beneficial effects on skeletal muscle size and function in cancer survivors.

Interventions

  • DEVICE Neuromuscular electrical stimulation

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2017-10-01
Est. Completion 2019-12-02
Phase NA

Sponsor

University of Vermont

162 total trials

What the Registry Record Tells You About NCT02739620

The ClinicalTrials.gov registry entry for NCT02739620 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Neuromuscular electrical stimulation is the first listed.

NCT02739620 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02739620 about?

NCT02739620 is a clinical study titled "Alternative Exercise Program to Improve Skeletal Muscle Function and Fatigue in Cancer Survivors". Exercise training has beneficial effects in cancer survivors to minimize some of the side effects of cancer and its treatment and improve long-term prognosis, but there are numerous hurdles for individuals diagnosed with, and being treated for, cancer to participate in exercise programs. The goal of...

What is the current status of trial NCT02739620?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2017-10-01. Estimated completion is 2019-12-02.

What interventions are being tested in trial NCT02739620?

The interventions under investigation include: Neuromuscular electrical stimulation (DEVICE).

Who is sponsoring clinical trial NCT02739620?

This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.